Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00072-9/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-9cWMcv9Wqva0OsCc9aZ4Qwz-arHdLVxGHmjl_kW6BxUPxofUqmn6S4RqvNCGAO61WrCtDDgO4PqBUj0rHJj3uAwWCd6Q&_hsmi=314845811&utm_content=314427349&utm_source=hs_email